Dr. Jeff Pearl

Dr. Jeff Pearl
Dr. Pearl received his undergraduate degree in Bioengineering at the University of Illinois in Urbana Champaign and went on from there to Northwestern University’s Feinberg School of Medicine in Chicago, IL. He completed his general surgical internship at Northwestern and his urology residency at Emory University in Atlanta, Georgia. While at Emory, Dr. Pearl’s in depth training spanned the breadth of urology practice including the management of stone disease, urologic oncology, benign prostatic hyperplasia, urinary incontinence and dysfunction, and erectile dysfunction. He received extensive training in minimally invasive urologic surgery including robotics and laparoscopy. Dr. Pearl has multiple publications and academic presentations including presenting at the plenary session of the American Urologic Association twice. His research endeavors have focused on telemedicine, Enhanced Recovery after Surgery (ERAS), frailty, kidney cancer outcomes, testosterone replacement therapy, and lower urinary tract symptoms. Additionally, he has received multiple awards throughout his training including the Emory Urology Academic Achievement Award twice, and the Northwestern Surgery Resident Teaching Award. Dr. Pearl lives in Deerfield, IL with his wife Jenny. With his free time, he enjoys staying active by cycling, hiking, and playing baseball. He’s a big Chicago sports fan and loves to watch the Cubs and Blackhawks.
Medical School:

Northwestern University Feinberg School of Medicine


Emory University


University of Illinois

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only